Given that autophagy is involved in the pathogenesis of many kidney diseases, and that AMPK regulates autophagic protection against kidney injury, AMPK is becoming a potential target for kidney disease therapy [18]. This evidence concerns the gene PRKAA2 and kidney disorder.